Clincosm LogoSign in Get a demo

Non Small Cell Lung Cancer

Showing NaN - NaN of 58
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +19 more
  • A2B694
  • xT CDx with HLA-LOH Assay
  • Duarte, California
  • +9 more
Sep 22, 2023

Non Small Cell Lung Cancer, Hepatocellular Carcinoma, Melanoma Trial in United States (MT-8421, Nivolumab)

Recruiting
  • Non Small Cell Lung Cancer
  • +10 more
  • Los Angeles, California
  • +4 more
Sep 5, 2023

Using Urine Samples to Identify Lung Cancer

Recruiting
  • Non Small Cell Lung Cancer
  • urine sample
  • Basking Ridge, New Jersey
  • +6 more
Sep 5, 2023

Non Small Cell Lung Cancer, Metastatic, Recurrent Trial in United States (Lorlatinib, Ramucirumab)

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
  • Middletown, New Jersey
  • +5 more
Aug 17, 2023

Invasive Ductal Breast Carcinoma, Invasive Ductal Breast Carcinoma Stage IV, Lobular Breast Carcinoma Trial in United States

Recruiting
  • Invasive Ductal Breast Carcinoma
  • +14 more
  • Stereotactic body radiotherapy
  • Lattice Radiation Therapy
  • Basking Ridge, New Jersey
  • +6 more
Apr 20, 2023

Non Small Cell Lung Cancer Trial in New York (Apricity C.A.R.E. Program for Cancer Adverse events Rapid Evaluation)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Apricity C.A.R.E. Program for Cancer Adverse events Rapid Evaluation
  • New York, New York
  • +3 more
Mar 31, 2023

Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +15 more
  • A2B530
  • xT-Onco with HLA-LOH Assay
  • Duarte, California
  • +6 more
Feb 10, 2023

Non Small Cell Lung Cancer, Stage III Non-small-cell Lung Cancer Trial in United States (device, drug, radiation, procedure)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Stage III Non-small-cell Lung Cancer
  • Durvalumab
  • +4 more
  • Chicago, Illinois
  • +3 more
Jan 18, 2023

Advanced Solid Tumor, Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma Trial in United States (STK-012,

Recruiting
  • Advanced Solid Tumor
  • +10 more
  • Boston, Massachusetts
  • +8 more
Jan 2, 2023

Non Small Cell Lung Cancer, KRAS Activating Mutation, Advanced Cancer Trial in United States (VS-6766 and adagrasib)

Recruiting
  • Non Small Cell Lung Cancer
  • +5 more
  • avutometinib (VS-6766) and adagrasib
  • San Francisco, California
  • +4 more
Dec 21, 2022

Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Metastatic, Non-small Cell Carcinoma Trial in United States (radiation,

Recruiting
  • Non Small Cell Lung Cancer
  • +4 more
  • L-SABR
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Dec 20, 2022

Non Small Cell Lung Cancer Trial in Worldwide (AZD9291)

Active, not recruiting
Has Results
  • Non Small Cell Lung Cancer
  • La Jolla, California
  • +43 more
Nov 25, 2022

Non Small Cell Lung Cancer, EGFR Exon 20 Mutation Trial in Worldwide (CLN-081)

Recruiting
  • Non Small Cell Lung Cancer
  • EGFR Exon 20 Mutation
  • Duarte, California
  • +18 more
Nov 11, 2022

Triple Negative Breast Cancer, Non Small Cell Lung Cancer, Metastatic Breast Cancer Trial in United States (Stereotactic Body

Recruiting
  • Triple Negative Breast Cancer
  • +3 more
  • Stereotactic Body Radiotherapy/SBRT
  • Systemic Therapy/Standard of Care
  • Hartford, Connecticut
  • +11 more
Aug 24, 2022

Non Small Cell Lung Cancer, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (Selpercatinib)

Available
  • Non Small Cell Lung Cancer
  • +6 more
  • Goodyear, Arizona
  • +67 more
Aug 17, 2022

Non Small Cell Lung Cancer, Breast Cancer Trial in Worldwide (Abemaciclib, Pembrolizumab, Anastrozole)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Breast Cancer
  • Fayetteville, Arkansas
  • +22 more
Aug 8, 2022

Mesothelioma, Non Small Cell Lung Cancer, Malignant Peripheral Nerve Sheath Tumors Trial in United States (MRTX1719)

Recruiting
  • Mesothelioma
  • +5 more
  • Denver, Colorado
  • +5 more
Aug 8, 2022

Solid Tumor, Adult, Head Neck Cancer, Non Small Cell Lung Cancer Trial in Worldwide (CX-2029)

Active, not recruiting
  • Solid Tumor, Adult
  • +4 more
  • Birmingham, Alabama
  • +24 more
Aug 5, 2022

TNBC - Triple-Negative Breast Cancer, Triple Negative Breast Cancer, NSCLC Trial in United States (Sterotactic Body

Active, not recruiting
  • TNBC - Triple-Negative Breast Cancer
  • +6 more
  • Sterotactic Body Radiotherapy/SBRT
  • Standard of care
  • Basking Ridge, New Jersey
  • +8 more
Jul 26, 2022

Pancreatic Cancer, Breast Cancer, Gastric Cancer Trial in Grand Rapids, New York, Houston (NGM438, Pembrolizumab)

Recruiting
  • Pancreatic Cancer
  • +15 more
  • Grand Rapids, Michigan
  • +2 more
Jul 18, 2022

Ovarian Cancer, Bladder Cancer, Non Small Cell Lung Cancer Trial in Worldwide (INCB106385, INCMGA00012)

Recruiting
  • Ovarian Cancer
  • +10 more
  • West Hollywood, California
  • +27 more
Jun 27, 2022

Lung Tumor, NSCLC, Respiratory Tract Tumors Trial in United States (BLU-701, osimertinib, carboplatin)

Recruiting
  • Lung Neoplasm
  • +26 more
  • Boston, Massachusetts
  • +6 more
Jun 23, 2022

Melanoma, Renal Cell Carcinoma, Non Small Cell Lung Cancer Trial in Worldwide (Combination of NKTR-214 + nivolumab)

Completed
  • Melanoma
  • +6 more
  • Combination of NKTR-214 + nivolumab
  • La Jolla, California
  • +57 more
Jun 22, 2022

Small Cell Lung Cancer, Ovarian Cancer, Breast Cancer Trial in United States (PF-07104091 monotherapy dose escalation,

Recruiting
  • Small Cell Lung Cancer
  • +4 more
  • PF-07104091 monotherapy dose escalation
  • +8 more
  • Clive, Iowa
  • +22 more
Apr 26, 2022

Melanoma, Non Small Cell Lung Cancer Trial in United States (VV1, Cemiplimab, Ipilumumab)

Recruiting
  • Melanoma
  • Non Small Cell Lung Cancer
  • VV1
  • +2 more
  • Phoenix, Arizona
  • +22 more
Apr 21, 2022